Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Ping An Healthcare and Technology Company Limited
It runs an online healthcare platform that connects Chinese consumers with doctors, online consultations, and medicine delivery.
Ping An Good Doctor is China's big online health platform, the app people open when they feel sick but don't want to sit in a crowded hospital waiting room. Users type their symptoms into a chat, get matched with a licensed doctor, and often walk away with advice or a digital prescription in minutes. The company also runs an online pharmacy that delivers medicine to the door, and it sells health checkup packages and wellness products alongside the core consultation service.
The way it makes money is straightforward: users pay for consultations and medicine, companies pay it to provide health services to their employees as a benefit, and insurers and hospitals partner with it to reach patients more cheaply. Its parent is the giant insurance group Ping An Insurance, which spun the business out and still backs it, and that relationship feeds it a steady stream of customers and corporate clients. Competition is fierce — Alibaba Health Information Technology and JD's health arm fight for the same users, and traditional hospitals are getting better at going digital too. The appeal for customers is convenience and price. A quick online consultation costs a fraction of a hospital visit, and for common problems — a cold, a skin rash, a prescription refill — it saves hours of travel and queuing. The hard part is that online medicine in China is tightly regulated, and the company has to keep proving its doctors are real and its prescriptions are safe. It has also struggled to turn a profit for years, spending heavily on user acquisition while margins on medicine stay thin.
Ping An Good Doctor went public in Hong Kong in 2018 at a rich valuation, riding a wave of optimism about internet healthcare. Since then the story has been more about grinding out sustainable profits than explosive growth. The company has pushed into corporate health plans and family doctor subscriptions, betting that recurring relationships beat one-off consultations. It remains a closely watched test of whether online healthcare in China can be both popular and profitable.
Saved answer · last researched 14 Nov 2026